Welcome to our dedicated page for Streamline Health Solutions In SEC filings (Ticker: STRM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Buried in Streamline Health’s revenue-cycle jargon, investors must untangle SaaS subscription accounting, hospital implementation costs, and ever-shifting healthcare regulations. Each new 10-K or 10-Q packs pages of pre-bill audit metrics and acquisition-related goodwill that are easy to miss. That complexity is exactly why we built Stock Titan’s AI-powered filing hub.
Our platform ingests every filing the moment it hits EDGAR and delivers plain-English answers to questions people really ask, such as “Streamline Health insider trading Form 4 transactions” or “understanding Streamline Health SEC documents with AI.” Whether you want a Streamline Health quarterly earnings report 10-Q filing summary, need the Streamline Health annual report 10-K simplified, or track a sudden 8-K material event explained, our AI highlights the revenue, margin, and ARR details that drive valuation.
Stop hunting through footnotes—our dashboard connects filing types to the insights that matter:
- Real-time Streamline Health Form 4 insider transactions with alerts on executive stock moves
- Segment roll-ups and SaaS growth rates pulled from each 10-Q earnings report
- Proxy snapshots showing Streamline Health executive compensation changes
- Automatic red-flag detection in Streamline Health 8-K disclosures—new contracts, CFO changes, system outages
Every document is paired with concise AI commentary so you can compare ARR momentum, see if revenue leakage solutions outpace services, and gauge cash burn—all without reading 200+ pages. That’s Streamline Health SEC filings explained simply. Spend less time decoding forms and more time acting on the data.
Form 144 filing for Etsy, Inc. (ETSY) discloses the planned sale of 1,500 common shares at an estimated aggregate market value of $75,075. The filer intends to execute the transaction on or about 07/01/2025 through UBS Financial Services, Inc. on the NASDAQ exchange.
The same individual—identified by the address "117 Adam Street, Brooklyn, NY 11201"—has already sold 4,500 Etsy shares in the last three months (1,500 shares on each of 04/01/2025, 05/01/2025, and 06/02/2025) for total gross proceeds of $225,140.70.
With 104,282,256 shares outstanding, the new proposed sale represents roughly 0.0014 % of Etsy’s total shares, indicating minimal dilution or ownership impact. No relationship to the issuer or 10b5-1 trading plan details are provided, and the filer affirms no undisclosed material information.
For investors, the filing signals continued, small-scale insider selling; while not material to share count, it may be a sentiment data-point to monitor if selling accelerates or expands in size.
Streamline Health Solutions, Inc. (Nasdaq: STRM) has filed a preliminary Schedule 14A seeking stockholder approval for its $5.34-per-share all-cash merger with Mist Holding Co., the parent of MDaudit. At closing, Merger Sub will merge into Streamline, which will become a wholly-owned subsidiary of MDaudit and cease to be publicly traded.
Key economic terms
- Cash consideration of $5.34 per share, representing a 138 % premium to the 5/28/25 close and 117 % to the 30-day VWAP.
- No financing contingency; Parent states it has sufficient cash on hand to fund the deal and related costs.
- Options and warrants with exercise prices below $5.34 will be cashed-out; all currently outstanding options and warrants are “out-of-the-money” and will be cancelled for no consideration.
- Termination fee payable by Streamline to Parent is $950 K; no reverse termination fee disclosed.
Governance & process
- The Streamline Board unanimously approved the merger, deemed it fair, and recommends voting “FOR” all proposals.
- Cain Brothers rendered a fairness opinion to the Board on 5/28/25.
- Certain directors and officers entered into Voting & Support Agreements, committing their shares to support the transaction (exact percentage not yet specified).
- Completion requires the affirmative vote of at least 66 2/3 % of outstanding shares. Failure to vote counts as an “AGAINST.”
Timeline & conditions
- Special Meeting will be held virtually on a date to be set; record date also to be set.
- Expected closing is Q3 2025, subject to stockholder approval and customary conditions (no financing or regulatory conditions highlighted).
- Outside date for termination is 12/31/25.
Post-closing the STRM shares will be delisted from Nasdaq and deregistered under the Exchange Act. Stockholders who properly perfect appraisal rights under Delaware law may seek a court-determined “fair value” instead of the $5.34 cash payment.
FAQ
What is the current stock price of Streamline Health Solutions In (STRM)?
What is the market cap of Streamline Health Solutions In (STRM)?
What does Streamline Health Solutions Inc specialize in?
How do their solutions improve the revenue cycle?
What industries are primarily served by Streamline Health Solutions?
What are the core components of their service offerings?
How does the company differentiate itself within the competitive healthcare IT market?
What technological innovations are central to their operations?
How do strategic partnerships enhance their service delivery?
Why is data integration critical in their solutions?
